Sutimlimab

ATC L04AJ04 · 4 markets · 4 records

Sutimlimab 4 markets · 4 records Forms

US 1 records · 1 strengths

ES 1 records · 1 strengths

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名Enjaymo ×2

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    FR 1 records · 1 strengths

    • 50 mg/1 mLinjectionENJAYMO 50 mg/ml, solution pour perfusion also in ES
    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.